Related Experiment Video
Updated: Feb 11, 2026

Invasive Behavior of Human Breast Cancer Cells in Embryonic Zebrafish
Published on: April 25, 2017
Low doses of Paclitaxel repress breast cancer invasion through DJ-1/KLF17 signalling pathway
Ismail Ahmed Ismail1,2, Gamal H El-Sokkary3, Saber H Saber2
1Faculty of Science, Department of Biology, Taibah University, Saudi, Arabia.
Abstract:
Paclitaxel (taxol) is an important agent against many tumours, including breast cancer. Ample data documents that paclitaxel inhibits breast cancer metastasis while others prove that paclitaxel enhances breast cancer metastasis. The mechanisms by which paclitaxel exerts its action are not well established. This study focuses on the effect of paclitaxel, particularly the low doses on breast cancer metastasis and the mechanisms that regulate it. Current results show that, paclitaxel exerts significant cytotoxicity even at low doses in both MCF-7 and MDA-MB-231 cells. Interestingly, paclitaxel significantly inhibits cell invasion and migration, decreases Snail and increases E-cadherin mRNA expression levels at the indicated low doses. Furthermore, paclitaxel-inhibiting breast cancer metastasis is associated with down-regulation of DJ-1 and ID-1 mRNA expression level with a concurrent increase in KLF17 expression. Under the same experimental conditions, paclitaxel induces KLF17 and concurrently represses ID-1 protein levels. Our results show for the first time that paclitaxel inhibits breast cancer metastasis through regulating DJ-1/KLF17/ID-1 signalling pathway; repressed DJ-1 and ID-1 and enhanced KLF17 expression.
Insights
Low doses of paclitaxel (taxol) inhibit breast cancer metastasis by affecting cell invasion and migration. This study reveals paclitaxel regulates the DJ-1/KLF17/ID-1 signaling pathway, impacting tumor spread.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Paclitaxel (taxol) is a key chemotherapy agent used against various tumors, including breast cancer.
- Conflicting evidence exists regarding paclitaxel's effect on breast cancer metastasis, and its underlying mechanisms remain unclear.
- This study investigates the impact of low-dose paclitaxel on breast cancer metastasis and its regulatory mechanisms.
Purpose of the Study:
- To determine the effect of low-dose paclitaxel on breast cancer cell invasion and migration.
- To elucidate the molecular mechanisms by which paclitaxel influences breast cancer metastasis.
- To identify key molecular targets and pathways regulated by paclitaxel in breast cancer.
Main Methods:
- Utilized MCF-7 and MDA-MB-231 breast cancer cell lines.
- Assessed cytotoxicity, cell invasion, and migration following paclitaxel treatment.
- Quantified mRNA and protein expression levels of key genes including Snail, E-cadherin, DJ-1, ID-1, and KLF17.
Main Results:
- Paclitaxel demonstrated significant cytotoxicity at low doses in both cell lines.
- Low-dose paclitaxel inhibited cell invasion and migration.
- Paclitaxel treatment led to decreased Snail and increased E-cadherin mRNA expression.
- Down-regulation of DJ-1 and ID-1 mRNA, alongside increased KLF17 mRNA, was observed.
- Paclitaxel induced KLF17 and repressed ID-1 protein levels.
Conclusions:
- Paclitaxel, even at low doses, inhibits breast cancer metastasis by reducing cell invasion and migration.
- The mechanism involves the regulation of the DJ-1/KLF17/ID-1 signaling pathway.
- Specifically, paclitaxel represses DJ-1 and ID-1 expression while enhancing KLF17 expression, thereby inhibiting metastasis.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

